| TEST NAME | INR RATE |
| TUMOR NECROSIS FACTOR (TNF)-Alpha, Serum | 5100 |
| PHOSPHO LIPASE A2 RECEPTOR ANTIBODY | 8200 |
| TB PLATINUM, IGRA | 2700 |
| PLATELET ANTIBODIES BY IFA – QUALITATIVE | 8160 |
| RISTOCETIN COFACTOR ASSAY | 17160 |
| Prothrombin Gene Mutation Analysis (G20210A) | 4300 |
| MTHFR (Methylene Tetra Hydro Folate Reductase) Gene Mutation | 4500 |
| PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) [CD55 & CD59] Confirmatory Test | 6000 |
| CD23 (CLL SEGREGATION MARKER) | 2100 |
| CD5 (T/B-CELL MARKER) | 2100 |
| HEPATITIS E VIRUS DETECTION by PCR | 7200 |
| NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE | 10800 |
| VITAMIN K | 13000 |
| TRYPTASE | 8700 |
| C1 ESTERASE INHIBITOR – FUNCTIONAL (C1 INACTIVATOR – FUNCTIONAL) | 4800 |
| C1 ESTERASE INHIBITOR – QUANTIFICATION (C1 INACTIVATOR – QUANTITATIVE) | 3800 |
| HEMOSIDERIN – URINE | 420 |
| METABOLIC DISORDER PANEL – URINE (INCLUDES 101 DIFFERENT ANALYTES TO DIAGNOSE 22 DIFFERENT METABOLIC DISORDERS) | 15000 |
| GILBERT’S SYNDROME GENE SEQUENCING | 9750 |
| CHLAMYDIA TRACHOMATIS PCR | 4300 |
| HPV SCREENING WITH REFLEX GENOTYPING FOR 32 SUBTYPES | 2200 |
| HUMAN PAPILLOMA VIRUS (HPV) GENOTYPING | 3000 |
| CH 50 (COMPLEMENT, TOTAL) | 4400 |
| Urine for Occult Blood | 200 |
| Tzank Smear | 510 |
| Aspirated Specimen for Culture – Anaerobic | 1800 |
| Tissue Transglutaminase IgG & IgA | 3000 |
| Tissue Transglutaminase IgG | 1500 |
| MHC-DRUG OF ABUSE TESTS ( 7 PANEL) | 3840 |
| Beta Cross Laps | 2500 |
| ACTIVATED PROTEIN C RESISTANCE (APCR) | 5500 |
| SPECIFIC IgE – ASPERGILLUS FUMIGATUS | 1500 |
| PORPHOBILINOGEN – 24 HRS URINE | 4300 |
| LIVER CYTOSOL ANTIBODY TYPE 1 (LC-1) | 4000 |
| Y-Chromosome Microdeletion | 8500 |
| CD – 19 | 2000 |
| ANCA-MPO / p-ANCA(IF) | 2120 |
| HOLOCOBALANINE(VIT-B12 ACTIVE) | 2000 |
| Melatonin | 3800 |
| HOMA INDEX C PEPTIDE MODEL | 1500 |
| STOOL CLOSTRIDIUM DIFFICILE TOXIN A/B | 2840 |
| CA 27 29 | 9000 |
| INSULINOMA ASSOCIATED AUTOANTIBODY (IA-2) | 6400 |
| ANAEROBIC BLOOD CULTURE & SENSITIVITY | 1800 |
| Lipid Associated – Sialic Acid | 9000 |
| Neutrophil Gelatinase Associated Lipocalin (N GAL) | 8950 |
| CMV (Cytomegalovirus) IgG Avidity | 800 |
| Sphingomyelinase Enzyme Assay | 4000 |
| Beta-Hexosaminidase A Enzyme Assay | 10000 |
| Manganese – Blood | 2500 |
| CELIAC DISEASE ANTIBODY PROFILE | 6800 |
| CD 99 | 1800 |
| Silver-Blood | 4500 |
| Pandy Test | 250 |
| Japanese Encephalitis Virus (JE Virus) | 4500 |
| IgG4 Subclass, Serum | 5900 |
| Serum Malarial Antibodies | 600 |
| GANGLIOSIDE IgG ANTIBODY PANEL, Serum | 4250 |
| GANGLIOSIDE IgM ANTIBODY PANEL, Serum | 4250 |
| CD10 | 2100 |
| CD13 | 2100 |
| CD33 | 2100 |
| NEONATAL SCREENING INBORN METABOLIC DISORDERS (IMD) PANEL | 9000 |
| NEONATAL SCREENING IMD PANEL (AMINOACIDS FATTY ACIDS ORGANIC ACIDS DISORDERS) | 6000 |
| Neonatal Screening Panel (42) parameters by Tandem Mass Spectrometry Method | 5000 |
| NEONATAL/NEWBORN SCREENING-I, 5 PARAMETERS (TSH, 17-OHP, G6PD, GALACTOSEMIA, PHENYLALANINE) | 2000 |
| NEONATAL/NEWBORN SCREENING-II, 7 PARAMETERS (TSH, 17-OHP, G6PD, GALACTOSEMIA, PHENYLALANINE, CFIRT, BIOTINIDASE) | 2300 |
| TSH – NEONATAL SCREEN | 400 |
| 17-OH PROGESTERONE – NEONATAL SCREEN | 330 |
| G6PD – NEONATAL SCREEN | 330 |
| GALACTOSEMIA – NEONATAL SCREEN | 330 |
| PHENYLALANINE – NEONATAL SCREEN | 330 |
| CYSTIC FIBROSIS IRT – NEONATAL SCREEN | 800 |
| BIOTINIDASE – NEONATAL SCREEN | 900 |
